Global Pre-Clinical Testing Service Market Research Report 2024

Publication ID:

PB505248342

Publication Date:

May 30, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Pre-clinical testing services refer to a range of scientific and technical services provided to pharmaceutical and biotechnology companies during the early stages of drug development. These services involve conducting various tests and experiments on potential drug candidates to evaluate their safety, efficacy, and pharmacokinetics before they can proceed to clinical trials in humans.
Pre-clinical testing services typically include in vitro studies, where the drug candidate is tested in a controlled laboratory environment using cells, tissues, or isolated biological components. These studies help assess the drug's mechanism of action, toxicity, and potential interactions with other substances.
Animal studies are also an essential part of pre-clinical testing services. These studies involve administering the drug candidate to animals, such as mice, rats, or non-human primates, to evaluate its safety, efficacy, and potential side effects. Animal studies help determine the appropriate dosage, identify potential toxicities, and provide insights into the drug's pharmacokinetics and pharmacodynamics.
Pre-clinical testing services may also include formulation development, where scientists work on optimizing the drug's formulation to enhance its stability, bioavailability, and delivery to the target site.
The global Pre-Clinical Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pre-Clinical Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pre-Clinical Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pre-Clinical Testing Service in Medicine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pre-Clinical Testing Service include Pacific BioLabs(PBL), Charles River, Shanghai Medicilon, Eurofins Scientific, Pharmaceutical Outsourcing, NAMSA, Creative Biolabs, KMI Diagnostics and H-J Family of Companies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pre-Clinical Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Clinical Testing Service.
Report Scope
The Pre-Clinical Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pre-Clinical Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pre-Clinical Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pacific BioLabs(PBL)
Charles River
Shanghai Medicilon
Eurofins Scientific
Pharmaceutical Outsourcing
NAMSA
Creative Biolabs
KMI Diagnostics
H-J Family of Companies
Phillips Medisize
Source Nutraceutical
Alanza
Elemental Analysis
Segment by Type
by Animal Model Species
Rabbit
Rat
Dog
Other
by Routes of Administration
Oral
Dermal
Intravenous
Subcutaneous
Intracutaneous
Intraperitoneal
Continuous Infusion
Intratracheal
Intrathecal
by Investigational Areas
Cardiovascular
Endocrine
Anti-infective
Oncology
Musculoskeletal
Dermal
Central Nervous System
Segment by Application
Medicine
Health Products
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pre-Clinical Testing Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Animal Model Species
1.2.1 Global Pre-Clinical Testing Service Market Size Growth Rate by Animal Model Species: 2019 VS 2023 VS 2030
1.2.2 Rabbit
1.2.3 Rat
1.2.4 Dog
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pre-Clinical Testing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medicine
1.3.3 Health Products
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pre-Clinical Testing Service Market Perspective (2019-2030)
2.2 Pre-Clinical Testing Service Growth Trends by Region
2.2.1 Global Pre-Clinical Testing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pre-Clinical Testing Service Historic Market Size by Region (2019-2024)
2.2.3 Pre-Clinical Testing Service Forecasted Market Size by Region (2025-2030)
2.3 Pre-Clinical Testing Service Market Dynamics
2.3.1 Pre-Clinical Testing Service Industry Trends
2.3.2 Pre-Clinical Testing Service Market Drivers
2.3.3 Pre-Clinical Testing Service Market Challenges
2.3.4 Pre-Clinical Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pre-Clinical Testing Service Players by Revenue
3.1.1 Global Top Pre-Clinical Testing Service Players by Revenue (2019-2024)
3.1.2 Global Pre-Clinical Testing Service Revenue Market Share by Players (2019-2024)
3.2 Global Pre-Clinical Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pre-Clinical Testing Service Revenue
3.4 Global Pre-Clinical Testing Service Market Concentration Ratio
3.4.1 Global Pre-Clinical Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Clinical Testing Service Revenue in 2023
3.5 Pre-Clinical Testing Service Key Players Head office and Area Served
3.6 Key Players Pre-Clinical Testing Service Product Solution and Service
3.7 Date of Enter into Pre-Clinical Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Clinical Testing Service Breakdown Data by Type
4.1 Global Pre-Clinical Testing Service Historic Market Size by Type (2019-2024)
4.2 Global Pre-Clinical Testing Service Forecasted Market Size by Type (2025-2030)
5 Pre-Clinical Testing Service Breakdown Data by Application
5.1 Global Pre-Clinical Testing Service Historic Market Size by Application (2019-2024)
5.2 Global Pre-Clinical Testing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pre-Clinical Testing Service Market Size (2019-2030)
6.2 North America Pre-Clinical Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pre-Clinical Testing Service Market Size by Country (2019-2024)
6.4 North America Pre-Clinical Testing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pre-Clinical Testing Service Market Size (2019-2030)
7.2 Europe Pre-Clinical Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pre-Clinical Testing Service Market Size by Country (2019-2024)
7.4 Europe Pre-Clinical Testing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pre-Clinical Testing Service Market Size (2019-2030)
8.2 Asia-Pacific Pre-Clinical Testing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pre-Clinical Testing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Pre-Clinical Testing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pre-Clinical Testing Service Market Size (2019-2030)
9.2 Latin America Pre-Clinical Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pre-Clinical Testing Service Market Size by Country (2019-2024)
9.4 Latin America Pre-Clinical Testing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pre-Clinical Testing Service Market Size (2019-2030)
10.2 Middle East & Africa Pre-Clinical Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pre-Clinical Testing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Pre-Clinical Testing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pacific BioLabs(PBL)
11.1.1 Pacific BioLabs(PBL) Company Detail
11.1.2 Pacific BioLabs(PBL) Business Overview
11.1.3 Pacific BioLabs(PBL) Pre-Clinical Testing Service Introduction
11.1.4 Pacific BioLabs(PBL) Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.1.5 Pacific BioLabs(PBL) Recent Development
11.2 Charles River
11.2.1 Charles River Company Detail
11.2.2 Charles River Business Overview
11.2.3 Charles River Pre-Clinical Testing Service Introduction
11.2.4 Charles River Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.2.5 Charles River Recent Development
11.3 Shanghai Medicilon
11.3.1 Shanghai Medicilon Company Detail
11.3.2 Shanghai Medicilon Business Overview
11.3.3 Shanghai Medicilon Pre-Clinical Testing Service Introduction
11.3.4 Shanghai Medicilon Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.3.5 Shanghai Medicilon Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pre-Clinical Testing Service Introduction
11.4.4 Eurofins Scientific Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 Pharmaceutical Outsourcing
11.5.1 Pharmaceutical Outsourcing Company Detail
11.5.2 Pharmaceutical Outsourcing Business Overview
11.5.3 Pharmaceutical Outsourcing Pre-Clinical Testing Service Introduction
11.5.4 Pharmaceutical Outsourcing Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.5.5 Pharmaceutical Outsourcing Recent Development
11.6 NAMSA
11.6.1 NAMSA Company Detail
11.6.2 NAMSA Business Overview
11.6.3 NAMSA Pre-Clinical Testing Service Introduction
11.6.4 NAMSA Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.6.5 NAMSA Recent Development
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Detail
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Pre-Clinical Testing Service Introduction
11.7.4 Creative Biolabs Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.7.5 Creative Biolabs Recent Development
11.8 KMI Diagnostics
11.8.1 KMI Diagnostics Company Detail
11.8.2 KMI Diagnostics Business Overview
11.8.3 KMI Diagnostics Pre-Clinical Testing Service Introduction
11.8.4 KMI Diagnostics Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.8.5 KMI Diagnostics Recent Development
11.9 H-J Family of Companies
11.9.1 H-J Family of Companies Company Detail
11.9.2 H-J Family of Companies Business Overview
11.9.3 H-J Family of Companies Pre-Clinical Testing Service Introduction
11.9.4 H-J Family of Companies Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.9.5 H-J Family of Companies Recent Development
11.10 Phillips Medisize
11.10.1 Phillips Medisize Company Detail
11.10.2 Phillips Medisize Business Overview
11.10.3 Phillips Medisize Pre-Clinical Testing Service Introduction
11.10.4 Phillips Medisize Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.10.5 Phillips Medisize Recent Development
11.11 Source Nutraceutical
11.11.1 Source Nutraceutical Company Detail
11.11.2 Source Nutraceutical Business Overview
11.11.3 Source Nutraceutical Pre-Clinical Testing Service Introduction
11.11.4 Source Nutraceutical Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.11.5 Source Nutraceutical Recent Development
11.12 Alanza
11.12.1 Alanza Company Detail
11.12.2 Alanza Business Overview
11.12.3 Alanza Pre-Clinical Testing Service Introduction
11.12.4 Alanza Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.12.5 Alanza Recent Development
11.13 Elemental Analysis
11.13.1 Elemental Analysis Company Detail
11.13.2 Elemental Analysis Business Overview
11.13.3 Elemental Analysis Pre-Clinical Testing Service Introduction
11.13.4 Elemental Analysis Revenue in Pre-Clinical Testing Service Business (2019-2024)
11.13.5 Elemental Analysis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Pacific BioLabs(PBL)
Charles River
Shanghai Medicilon
Eurofins Scientific
Pharmaceutical Outsourcing
NAMSA
Creative Biolabs
KMI Diagnostics
H-J Family of Companies
Phillips Medisize
Source Nutraceutical
Alanza
Elemental Analysis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂